These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3268822)

  • 1. [Use of calcium channel blockers in gastroenterology].
    Markiewicz A; Martynowicz M
    Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1679-83. PubMed ID: 3268822
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium-channel blockers and the gastrointestinal tract. American College of Gastroenterology's Committee on FDA related matters.
    Traube M; McCallum RW
    Am J Gastroenterol; 1984 Nov; 79(11):892-6. PubMed ID: 6391152
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of calcium antagonists on esophageal motor activity in cardial achalasia].
    Stepenko AS; Nechaev VM
    Klin Med (Mosk); 1988 Jun; 66(6):72-5. PubMed ID: 3184808
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium channel blockers and motility disorders of the esophagus.
    Andersson KE
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():201-4. PubMed ID: 3716828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of achalasia].
    Wienbeck M; Barnert J
    Dtsch Med Wochenschr; 1989 Dec; 114(50):1971-3. PubMed ID: 2689124
    [No Abstract]   [Full Text] [Related]  

  • 6. Esophageal motility disorders: medical therapy.
    Lacy BE; Weiser K
    J Clin Gastroenterol; 2008; 42(5):652-8. PubMed ID: 18364589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calcium channel blockers as therapeutic agents except for cardiovascular diseases].
    Kohara K
    Clin Calcium; 2004 Apr; 14(4):639-43. PubMed ID: 15577024
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium-channel blockers and gastrointestinal motility: basic and clinical aspects.
    De Ponti F; Giaroni C; Cosentino M; Lecchini S; Frigo G
    Pharmacol Ther; 1993 Oct; 60(1):121-48. PubMed ID: 8127922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium and contraction of digestive smooth muscle].
    Bouchoucha M; Drevillon C; Arhan P
    Gastroenterol Clin Biol; 1989 Oct; 13(10):822-8. PubMed ID: 2687072
    [No Abstract]   [Full Text] [Related]  

  • 10. [Employment of calcium antagonists in extracardial diseases].
    Husted SE; Nielsen HK; Krusell LR
    Ugeskr Laeger; 1986 Mar; 148(12):705-8. PubMed ID: 3961966
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-surgical treatment of esophageal achalasia.
    Annese V; Bassotti G
    World J Gastroenterol; 2006 Sep; 12(36):5763-6. PubMed ID: 17007039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium blockers in smooth-muscle disorders. Current status.
    Schwartz ML; Rotmensch HH; Vlasses PH; Ferguson RK
    Arch Intern Med; 1984 Jul; 144(7):1425-9. PubMed ID: 6375615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of calcium antagonists in the clinical treatment of internal diseases].
    Moiseev VS; Ivleva AIa; Akopian LM
    Ter Arkh; 1987; 59(3):132-8. PubMed ID: 3299850
    [No Abstract]   [Full Text] [Related]  

  • 14. Update on the management of achalasia: balloons, surgery and drugs.
    Richter JE
    Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):435-45. PubMed ID: 19072391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of noncardiac chest pain in older patients.
    Castell DO
    Geriatrics; 1985 Oct; 40(10):61-3, 67, 70 passim. PubMed ID: 4043738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutical alternatives in achalasia.
    Ruiz de León San Juan A
    Rev Esp Enferm Dig; 2003 Jan; 95(1):5-8, 9-12. PubMed ID: 12760726
    [No Abstract]   [Full Text] [Related]  

  • 17. An overview of the role of calcium antagonists in the treatment of achalasia and diffuse oesophageal spasm.
    Short TP; Thomas E
    Drugs; 1992 Feb; 43(2):177-84. PubMed ID: 1372216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Esophageal achalasia].
    Frol'kis AV
    Sov Med; 1986; (6):44-8. PubMed ID: 3529447
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction of post-prandial motility by pinaverium bromide a calcium channel blocker acting selectively on the gastrointestinal tract in patients with irritable bowel syndrome.
    Awad RA; Cordova VH; Dibildox M; Santiago R; Camacho S
    Acta Gastroenterol Latinoam; 1997; 27(4):247-51. PubMed ID: 9401097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What is assured in therapy of gastrointestinal diseases with drugs acting on motility?].
    Müller-Lissner S; Klauser A
    Internist (Berl); 1989 Dec; 30(12):797-804. PubMed ID: 2695489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.